Search for the latest oncology news by tumour type
Reprogrammed immune cells fight off melanoma in lab model
A new way of reprogramming our immune cells to shrink or kill off cancer cells…
Browsing: Tumour Stream
Artificial intelligence approach may help identify melanoma survivors who face a high risk of cancer recurrence
Most deaths from melanoma occur in patients who were initially diagnosed with early-stage melanoma and…
Study predicts lethal prostate cancer risk using genetic scores
Researchers at University of California San Diego School of Medicine, USA, with colleagues elsewhere, report…
Possible biological explanation for increased cancer risk in dense breasts
The risk of developing breast cancer is higher in what are known as dense breasts,…
Gel-like, radioactive tumour implant effective against pancreatic cancer in mice
Researchers at Duke University, USA, have demonstrated the most effective treatment for pancreatic cancer ever…
Cervical cancer discovery offers major new clue to better understand the disease
Scientists have discovered that cervical cancer can be divided into two distinct molecular subgroups –…
Study finds earlier mammograms for women with family history of breast cancer may not be needed
A new study released in the American Cancer Society journal Cancer reconsiders guidelines for when to start screening with mammograms if…
ASTRO 2022: Shortened course of radiation therapy safe and effective for men with high-risk prostate cancer
A new randomised study confirms that men with high-risk prostate cancer can be treated with…
ASTRO 2022: Three week hypo-fractionated whole breast irradiation (WBI) with concurrent boost not inferior to conventional WBI with a sequential boost following lumpectomy for high-risk, early-stage breast cancer
Results from the analysis of the NRG Oncology RTOG 1005 clinical trial data concluded that…
ASTRO 2022: Lower prostate cancer screening rates associated with subsequent increase in advanced cancers
In the face of conflicting evidence over the risks and benefits of routine prostate cancer…